Selected top branded biologic drugs in the United States that will go generic between 2016 and 2028, by revenue (in billion U.S. dollars)*

Top branded biologic drugs in the U.S. that will go generic by 2028 This statistic shows a list of selected top branded biologic drugs in the United States that will go generic by 2028 as a result of expired patents, listed by revenue. One of these top branded drugs is Humira, which generates around 8.5 billion U.S. dollars worth of revenue in the U.S. pharmaceutical market annually and will go generic in 2016.
Show more
Loading statistic...
Drug name and date of patent expiryRevenue in billion U.S. dollars
Humira (2016)8.5
Rituxan (2016)3.6
Remicade (2018)4.7
Enbrel (2028)6.1
Drug name and date of patent expiryRevenue in billion U.S. dollars
Humira (2016)8.5
Rituxan (2016)3.6
Remicade (2018)4.7
Enbrel (2028)6.1

© Statista 2017

Download Settings Share
Chart type
Datalabels
Share on Social Media
HTML code to embed chart as PNG (FAQ)
Download started
Please be patient - this may take a moment
Description Source More information
This statistic shows a list of selected top branded biologic drugs in the United States that will go generic by 2028 as a result of expired patents, listed by revenue. One of these top branded drugs is Humira, which generates around 8.5 billion U.S. dollars worth of revenue in the U.S. pharmaceutical market annually and will go generic in 2016.
Show more
Release date
2016
Region
United States
Survey time period
2016
Supplementary notes
* For all of these drugs, the existing patent will expire by 2028, which allows generic versions to then be made thereafter. The statistic is based on U.S. revenue only.
Revenue figures are the moving annual total (MAT) for June 2015.

Statista Accounts: Access All Statistics. Starting from $588 / Year

Statistics on "U.S. pharmaceutical industry"

  • Contribution to global pharma
The most important statistics
  • Overview
  • Companies
  • Research and development
The most important statistics
  • Generics
The most important statistics
  • Outlook
  • The consumer's view
The most important statistics

Related Studies: Available to Download in PDF or PPTX Format

U.S. pharmaceutical industry

All Information
in one Presentation

U.S. pharmaceutical industry

Everything On "U.S. pharmaceutical industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista for Your Company: The Research and Analysis Tool

  • Product Film
  • Statistics
  • Downloads

Our Premium Statistics - facts for your business

Currently, Statista provides more than 1 million statistics.
93 percent (all Premium content) are exclusively accessible via our professional accounts.

Unlimited access

As a Statista Premium customer, you receive unlimited access to all statistics at all times. Including downloads of data in the most common formats (XLS, PDF & PNG). Create relevant and significant statistics in no time.

You are in good company

Further Content: Statistics, Studies, and Topic Pages

Our Business Solutions: Save Time and Money

only

$588*

per year
Your advantages
  • Full access to all our statistics
  • Download as XLS, PDF & PNG
  • Relevant data: complete source information
All functions of our platform illustrated face-to-face
  • Learn how Statista supports your company
  • Extensive tour across the whole portal
  • Personal guidance by our support team
The knowledge database for your company
  • All functions of the Premium Account
  • Access to dossiers, forecasts and studies
  • Access to our international database
  • Publishing rights and other exclusive functions

Statistics on the topic

Topics

About Statista

Learn more about how Statista can support your business.

Request webinar